Elevating Malawi’s Local Enterprises: A Nation Online Insight

Key Business Points

• Local production opportunities: New import taxes on common medicines create a massive gap for local pharmaceutical startups to produce drugs internally.
• Cost of doing business: Importers of Paracetamol and Malaria treatments will face higher tariffs of 25 percent, increasing the cost of imported supplies.
• Focus on quality: Success for local manufacturers depends on meeting strict international standards for packaging and storage to win consumer trust.

The Malawi Government has introduced new surcharge taxes on several essential medicines to drive local industrialisation and reduce the heavy reliance on expensive imports. Under the new measures, imports of Amoxicillin will attract a 20 percent duty, while Paracetamol, Aspirin, Ibuprofen, and Artemether-Lumefantrine will now face a 25 percent tariff.

This shift is a strategic move to stop the heavy outflow of ndalama (money) from the country. Current data reveals that Malawi spent roughly $95 million on pharmaceutical imports in 2025. Because over 90 percent of medicines are imported, the government aims to use this "targeted protectionism" to encourage the growth of homegrown businesses.

Industry experts, including the Pharmaceutical Association of Malawi (Phasom), believe this is a golden opportunity to save foreign exchange and create new jobs. However, they warn that for this bizinesi (business) to truly succeed, local producers must prioritise high quality and proper storage. If local alternatives are not reliable, consumers may still choose expensive imports to protect their health.

To support this transition, the government is partnering with the Malawi University of Science and Technology (MUST) and Rephaiah Pharmaceuticals. They are developing a $65 million manufacturing facility that will start with pediatric medicines before expanding into antibiotics and antiretroviral drugs. This project aims to not only serve the local market but also export high value medicines to other regions.

The National Planning Commission notes that this is a short term measure to support value addition and industrial growth. To ensure a fair market, officials emphasize that these benefits should be open to the wider industry rather than a single dominant player. This creates a fertile ground for partnerships between universities and private entrepreneurs.

This policy comes at a critical time. Malawi has struggled with severe foreign exchange shortages since 2020, which has made it difficult for the Central Medical Stores Trust and other suppliers to deliver essential drugs. By shifting from importing to manufacturing, the country can build health security and stabilize its trade balance.

For local investors and entrepreneurs, the focus should now shift toward pharmaceutical infrastructure and supply chain logistics. Those who can bridge the gap in production and distribution will be well positioned to capture a market that currently depends almost entirely on foreign sources. This is a clear call for domestic investment in science and industry to turn a health necessity into an economic engine.

Source Link

What are your thoughts on this business development? Share your insights and remember to follow us on Facebook and Twitter for the latest Malawi business news and opportunities. Visit us daily for comprehensive coverage of Malawi’s business landscape.